Patient experience with chronic obstructive pulmonary disease: a nationally representative demonstration study on quality and cost of healthcare services.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2023
Historique:
received: 02 12 2022
accepted: 16 05 2023
medline: 5 7 2023
pubmed: 3 7 2023
entrez: 3 7 2023
Statut: epublish

Résumé

Due to insufficient data on patient experience with healthcare system among patients with chronic obstructive pulmonary disease (COPD), particularly in developing countries, this study attempted to investigate the journey of patients with COPD in the healthcare system using nationally representative data in Iran. This nationally representative demonstration study was conducted from 2016 to 2018 using a novel machine-learning based sampling method based on different districts' healthcare structures and outcome data. Pulmonologists confirmed eligible participants and nurses recruited and followed them up for 3  months/in 4 visits. Utilization of various healthcare services, direct and indirect costs (including non-health, absenteeism, loss of productivity, and time waste), and quality of healthcare services (using quality indicators) were assessed. This study constituted of a final sample of 235 patients with COPD, among whom 154 (65.5%) were male. Pharmacy and outpatient services were mostly utilized healthcare services, however, participants utilized outpatient services less than four times a year. The annual average direct cost of a patient with COPD was 1,605.5 USDs. Some 855, 359, 2,680, and 933 USDs were imposed annually on patients with COPD due to non-medical costs, absenteeism, loss of productivity, and time waste, respectively. Based on the quality indicators assessed during the study, the focus of healthcare providers has been the management of the acute phases of COPD as the blood oxygen levels of more than 80% of participants were documented by pulse oximetry devices. However, chronic phase management was mainly missed as less than a third of participants were referred to smoking and tobacco quit centers and got vaccinated. In addition, less than 10% of participants were considered for rehabilitation services, and only 2% completed four-session rehabilitation services. COPD services have focused on inpatient care, where patients experience exacerbation of the condition. Upon discharge, patients do not receive appropriate follow-up services targeting on preventive care for optimal controlling of pulmonary function and preventing exacerbation.

Identifiants

pubmed: 37397720
doi: 10.3389/fpubh.2023.1112072
pmc: PMC10308222
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1112072

Informations de copyright

Copyright © 2023 Ghamari, Mohebi, Abbasi-Kangevari, Peiman, Rahimi, Ahmadi, Farzi, Seyfi, Shahbal, Modirian, Azmin, Zokaei, Khezrian, Sherafat, Malekpour, Roshani, Rezaei, Fallahi, Shoushtari, Akbaripour, Khatibzadeh and Shahraz.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Lancet. 2007 Sep 1;370(9589):786-96
pubmed: 17765528
BMC Health Serv Res. 2020 May 6;20(1):382
pubmed: 32375767
Front Public Health. 2020 Dec 16;8:571062
pubmed: 33415092
NPJ Prim Care Respir Med. 2020 Oct 16;30(1):46
pubmed: 33067469
Chest. 2015 May;147(5):1219-1226
pubmed: 25539483
BMC Public Health. 2020 Mar 19;20(1):359
pubmed: 32188428
Lancet. 2019 May 11;393(10184):1984-2005
pubmed: 31043324
Can Respir J. 2011 Jul-Aug;18(4):216-20
pubmed: 22059179
Front Endocrinol (Lausanne). 2023 Mar 16;14:1099464
pubmed: 37008899
BMC Pulm Med. 2016 May 10;16(1):70
pubmed: 27160582
Pharmacoeconomics. 2017 Jan;35(1):43-63
pubmed: 27592021
Int J Chron Obstruct Pulmon Dis. 2015 Dec 03;10:2609-18
pubmed: 26664109
Int J Chron Obstruct Pulmon Dis. 2019 Jul 05;14:1423-1439
pubmed: 31308648
BMC Public Health. 2021 Jul 17;21(1):1414
pubmed: 34273940
Arch Bronconeumol. 2013 Jun;49(6):223-9
pubmed: 23317767
NPJ Prim Care Respir Med. 2017 Dec;27(1):11
pubmed: 28202995
BMJ Open. 2014 Dec 22;4(12):e006414
pubmed: 25534212
Am J Respir Crit Care Med. 2018 Mar 1;197(5):611-620
pubmed: 29323928
Respir Med. 2017 Jul;128:85-91
pubmed: 28610675
BMC Pulm Med. 2014 Aug 09;14:134
pubmed: 25107380
Int J Chron Obstruct Pulmon Dis. 2017 Mar 21;12:961-971
pubmed: 28356728
Ann Am Thorac Soc. 2020 Jan;17(1):49-56
pubmed: 31599647
J Am Coll Cardiol. 2019 Feb 19;73(6):727-732
pubmed: 30765039
Expert Rev Pharmacoecon Outcomes Res. 2020 Dec;20(6):661-672
pubmed: 31596632
Lancet. 2018 Apr 21;391(10130):1550
pubmed: 29695330
Am J Respir Crit Care Med. 2016 Feb 1;193(3):251-8
pubmed: 26414484
Respir Med. 2011 Jun;105(6):930-8
pubmed: 21367593
Oncologist. 2013;18(4):381-90
pubmed: 23442307
Hum Vaccin Immunother. 2018;14(11):2715-2721
pubmed: 29995561
Am J Respir Crit Care Med. 2009 Mar 1;179(5):369-74
pubmed: 19074596
Br J Community Nurs. 2013 Aug;18(8):398, 400-3
pubmed: 24225475
Respir Res. 2023 Mar 11;24(1):74
pubmed: 36906596
Anaesthesist. 2019 Nov;68(11):762-769
pubmed: 31690959
Lancet. 2012 Jan 7;379(9810):47-54
pubmed: 22169105
Am J Respir Crit Care Med. 2018 Dec 1;198(11):1367-1374
pubmed: 30601674
EClinicalMedicine. 2023 May;59:101936
pubmed: 37229504
Eur Respir J. 2017 Sep 9;50(3):
pubmed: 28889106
Respir Med. 2019 Sep;156:58-68
pubmed: 31437649
Am J Respir Crit Care Med. 2021 Jan 1;203(1):24-36
pubmed: 33146552
Int J Chron Obstruct Pulmon Dis. 2011;6:259-67
pubmed: 21814462
Am J Health Syst Pharm. 2020 Feb 7;77(4):259-268
pubmed: 31930287
Proc Am Thorac Soc. 2007 Dec;4(8):680-2
pubmed: 18073402
BMC Health Serv Res. 2021 Aug 17;21(1):828
pubmed: 34404393

Auteurs

Seyyed-Hadi Ghamari (SH)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Farnam Mohebi (F)

Haas School of Business, University of California, Berkeley, CA, United States.

Mohsen Abbasi-Kangevari (M)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Soheil Peiman (S)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Besharat Rahimi (B)

Department of Internal Medicine, AdventHealth Orlando Hospital, Orlando, FL, United States.

Naser Ahmadi (N)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Yousef Farzi (Y)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Shahedeh Seyfi (S)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Nazila Shahbal (N)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Mitra Modirian (M)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Mehrdad Azmin (M)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Hossein Zokaei (H)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Maryam Khezrian (M)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Roya Sherafat (R)

Heller School of Social Policy and Management, Brandeis University, Waltham, MA, United States.

Mohammad-Reza Malekpour (MR)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Shahin Roshani (S)

The Netherlands Cancer Institute (NKI), Amsterdam, Netherlands.

Negar Rezaei (N)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Mohammad Javad Fallahi (MJ)

Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Maryam Haddadzadeh Shoushtari (MH)

Air Pollution and Respiratory Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Zahra Akbaripour (Z)

Razi University Hospital, Guilan University of Medical Sciences, Guilan, Iran.

Shahab Khatibzadeh (S)

Heller School of Social Policy and Management, Brandeis University, Waltham, MA, United States.

Saeid Shahraz (S)

Tufts Medical Center, Institute for Clinical Research and Health Policy Studies, Boston, MA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH